Peptide ibdipotide-tseem hu ua dawb adipose vasculature-targeted proapoptotic peptide-yog ib qho kev tsim kho ntawm chimeric peptide uas covalently txuas cov adipose- xaiv vascular homing motif rau mitochondria- cuam tshuam proapoptotic ib ntus. N-terminal ntu yog ib lub voj voog adipose-vascular homing motif tsim los ntawm Cys-Cys disulfide daim ntawv cog lus, thaum C-terminal ntu yog ib qho amphipathic, cationic D-peptide suav nrog ob lub tandem KLAKLAK rov ua dua, txuas los ntawm kev hloov pauv Gly-Gly txuas. Homing motif khi ib qho receptor complex ntawm endothelium ntawm cov ntaub so ntswg dawb (WAT), nyob rau hauv txwv tsis pub (PHB); ib zaug nyob rau hauv, lub proapoptotic cargo cuam tshuam mitochondrial daim nyias nyias thiab ua rau endothelial apoptosis, yog li xaiv devascularizing adipose ntaub so ntswg thiab, nyob rau hauv lem, inducing adipocytes atrophy thiab txo cov rog rog.
Shaanxi Medibridge muab adipotide (WAT-targeted proapoptotic peptide) ntawm ntau dua lossis sib npaug li 99% purity rau kev tshawb fawb siv nkaus xwb. Raws li kev koom tes nrog peptide rau cov tsev kawm ntawv qib siab thiab cov chaw tshawb fawb thoob ntiaj teb, peb muab cov kev cai sib xyaw ua ke, los ntawm milligram mus rau multigram nplai, nrog QC ruaj khov, suav nrog HPLC thiab MS cov ntaub ntawv thiab ntau ntau - daim ntawv pov thawj tshwj xeeb ntawm kev tshuaj xyuas.

COA
|
|
||
|
Khoom npe |
CAS Nr |
Batch Number |
|
Peptide adipotide hmoov |
859216-15-2 |
MB2509081549 |
|
Hnub tim tsim khoom |
Hnub Soj Ntsuam |
Hnub Kawg |
|
2025-11-09 |
2025-11-10 |
2027-11-08 |
|
Qauv Qty Base |
Ntim |
Txoj Kev Xeem |
|
860.52 GS |
5GS / lub raj mis |
HPLC |
|
Yam khoom |
Txuj |
Cov txiaj ntsig |
|
Purity |
Ntau dua lossis sib npaug li 98% |
99.13% |
|
Peptide Assay |
Ntau dua lossis sib npaug li 80% |
85.63% |
|
Loj Spectrum |
2557.21 |
2557.21 |
|
Solubility |
Soluble hauv dej |
Ua raws |
|
Clarity thiab xim ntawm kev daws |
Ntshiab thiab tsis muaj xim |
Ua raws |
|
Sodium ntsev |
<5.0% |
1.98% |
|
Dej |
Tsawg dua lossis sib npaug li 7.0% |
3.21% |
|
Residual Solvent: |
||
|
Methanol |
Tsawg dua lossis sib npaug li 0.3% |
Ua raws |
|
Isopropanol |
Tsawg dua los yog sib npaug li 0.5% |
0.158% |
|
Cov tshuaj acetonitrile |
Tsawg dua lossis sib npaug li 0.041% |
0.019% |
|
Methylene Chloride |
Tsawg dua lossis sib npaug li 0.06% |
0.028% |
|
N,N{0}}Dimethylformamide |
Tsawg dua lossis sib npaug li 0.088% |
Ua raws |
|
Triethylamine |
Tsawg dua lossis sib npaug li 0.032% |
Ua raws |
|
Tert -butyl methyl ether |
Tsawg dua los yog sib npaug li 0.5% |
0.173% |
|
Endotoxin |
Tsawg dua lossis sib npaug li 0.5 EU / mg |
Ua raws |
|
Microbial txwv |
Tag nrho cov kab mob aerobic<100 CFU/g Tag nrho cov poov xab & pwm<50 CFU/g |
<50 CFU/g <10 CFU/g |
|
Cia |
Khaws rau hauv qhov chaw tsaus thiab txias qhuav (-20 txog 8 degree) |
|
|
Xaus |
Cov batch ua raws li IN-HOUSE tus qauv |
|
|
|
||
Specification (rau kev tshawb fawb siv nkaus xwb)
Vim li cas thiaj xaiv peb
1. High Purity thiab Structural Confirmation: Peb muab cov khoom no nrog ntau dua los yog sib npaug rau 99% purity thiab suav nrog batch COA / purity spectrum.
2. Stable thiab Reproducible: Lyophilized hmoov mov, kom ruaj khov cyclization conformation thiab sequence integrity.
3. Kev hloov kho yooj yim: Txhawb mg-multigram-kg qib kev hloov kho.
4. Kev Pabcuam Muab Kev Pabcuam: Muab cov lus qhia solubility thiab buffer system cov lus qhia, khaws cia thiab rov tsim kho cov txheej txheem, cov txheej txheem siv, thiab ib qho - ntawm - ib qho lus teb ceev ceev los ntawm cov kws tshaj lij engineers.
5. Txhim khu kev xa khoom: Lub teeb thoob ntiaj teb - thiab ya raws - pov thawj ntim, ua kom ruaj khov thiab ua haujlwm tau zoo los ntawm kev xaj xaj mus rau qhov tau txais.
6. Kev ua raws cai thiab tus nqi-Kev ua tau zoo: Lub hom phiaj kev tshawb fawb daim ntawv thov, pob tshab pricing, 4-6 hnub xa khoom, ua kom muaj kev sim ua tau zoo hauv kev siv nyiaj txiag.
|
Daim ntawv |
Qauv Order |
Specification |
|
Cov hmoov nyoos |
1 g |
Purity yog NLT 99% |
|
Vials |
10 vials |
3ml / 5ml / 7ml / 15ml vials thiab lwm yam. |
Mechanism ntawm kev ua
Xaiv qhov localization
Lub cyclic CKGGRAKDC motif khi txwv tsis pub ntawm WAT endothelium, ua rau adipose- tshwj xeeb homing thiab endocytosis; qhov no tau tsim los ntawm Kolonin li al., uas thim rov qab rog rog hauv nas los ntawm kev tsom mus rau txwv tsis pub nrog KLAK cov khoom thauj.
Mitochondrial cuam tshuam
Internalized D (KLAKLAK)2 tsoo cov mitochondrial daim nyias nyias muaj peev xwm thiab ua rau intrinsic apoptosis nyob rau hauv endothelial hlwb, ib tug zoo- yam ntxwv nyhuv ntawm lub hom phiaj KLAK tsim.
Cov ntaub so ntswg
Endothelial apoptosis ua rau vascular rarefaction thiab depot shrinkage; Hauv cov rog rog rhesus macaques muab adipotide 0.43 mg / kg SC txhua hnub rau 28 hnub, lub cev hnyav poob 7.4-14.7% (txhais tau −10.6%), DEXA rog −38.7%, thiab plab MRI WAT −17.5% tom kawg-2.0{8. kawg-ntawm-rov qab).
Cov txiaj ntsig metabolic
Insulin AUC thaum lub sij hawm IVGTT txo qis 36.2% thiab insulinogenic Performance index -48.5% hauv cov macaques kho, qhia txog kev txhim kho insulin rhiab heev; Kev noj zaub mov tsis zoo thaum noj tshuaj thiab rov qab los tom qab noj mov.

Kev sib piv cov cuab yeej nrog cov khoom siv tshuaj tiv thaiv -kev rog rog (rau kev sib pauv kev kawm nkaus xwb)
|
Yam |
GLP 1 / Dual (GLP 1 / GIP) |
Peptide adipotide hmoov |
|
Mechanism ntawm kev ua |
Central qab los noj mov - satiety txoj kev; ncua lub plab khoob; broad metabolic teebmeem |
Peripheral targeting ntawm WAT vasculature; "supply → apoptosis → atrophy" cascade kom txo cov rog rog |
|
Lub hom phiaj tseem ceeb |
CNS thiab plab-pancreas axis |
Dawb adipose cov ntaub so ntswg endothelium |
|
CNS dependence |
Siab |
Tsawg |
|
Metabolic effect Scope |
Kev txhim kho metabolic dav dav |
Kev txo cov rog rog nrog cov txiaj ntsig hauv qab dej metabolism |
|
Lub tswv yim analogy |
Neuroendocrine metabolic re tuning |
Cov ntaub so ntswg selective ablation |
|
Kev sib xyaw muaj peev xwm |
Theoretically complementary; xav tau kev kuaj mob validation |
Theoretically complementary; xav tau kev kuaj mob validation |
Cov Lus Nug Txog Kev Tshawb Fawb thiab Cov Tswv Yim Zoo Tshaj Plaws
Tus neeg mob stratification
Cov pov thawj: Hauv tib txoj kev tshawb fawb rhesus, cov tsiaj rog rog tau poob phaus (txhais tau tias −10.6%, thaj tsam −7.4% rau −14.7%); lean macaques ntawm cov tshuaj kho tsis tau pom qhov poob zoo sib xws, qhia txog kev ua tau zoo ntawm phenotype-dependent (28-hnub SC dosing; Sci Transl Med 2012). Mechanistically, CKGGRAKDC lub tsev txwv tsis pub WAT endothelium (mouse phage-display/targeted-ablation thwmsim; Nature Medicine 2004), implying target-expression variability across depots.
Txoj Kev: Txhim kho cov neeg mob uas muaj visceral-dominant adiposity los ntawm MRI; ua ntaub ntawv PHB lub hom phiaj hauv WAT (biopsy IHC lossis tracer uptake) thiab yuav tsum tau khaws cia raum ua haujlwm ntawm lub hauv paus (eGFR/albuminuria) kom txo qis kev pheej hmoo.

Biomarkers
Lub hom phiaj kev koom tes / PD: Siv tib qhov kev nyeem ntau uas tau ua pov thawj hauv qhov kev sim rhesus -DEXA rog rog (−38.7%), plab MRI WAT ntim (−17.5% kawg ntawm-kev kho mob; −27.0% kawg ntawm-rov qab), thiab IVGTT 38.7% insulin metrics (insulin 38.7%) −48.5%)-raws li thawj PD cov cim (28-hnub SC txoj kev kawm; Sci Transl Med 2012).Kev nyab xeeb: taug qab tubular raug mob thaum ntxov nrog zis NGAL/KIM-1 nrog rau cov ntshav creatinine/cystatin C; txhais cov cai txwv rau kev kho mob nce, tom qab ntawd paub meej tias kev rov qab los thaum ntxuav tawm (raws li NHP toxicity signals saum toj no).

FAQ
Q: MOA yog dab tsi?
A: CKGGRAKDC lub hom phiaj txwv tsis pub ntawm WAT endothelium; D (KLAKLAK)2 cuam tshuam mitochondria → endothelial apoptosis → depot shrinkage.
Q: Dab tsi yog cov ntsiab lus tseem ceeb?
A: c[CKGGRAKDC]–GG–D(KLAKLAK)2; purity Ntau dua lossis sib npaug li 99% (HPLC); LC-MS tau lees paub; COA muab.
Q: Yuav ua li cas reconstitute / khw?
A: Sterile dej / PBS (pH ~ 7), 1-5 mg / mL; aliquot; tsis txhob khov-thaw; lyophilized ntawm -20 txog -80 degree.
Q: Puas muaj kev siv tshuaj noj (preclinical)?
A: Rhesus: 0.43 mg/kg SC QD × 28 hnub; nas: QD × 2–4 lub lis piam; suav nrog lub tsheb/scrambled tswj.
Q: Kev saib xyuas kev nyab xeeb tseem ceeb?
A: Lub raum: ntshav creatinine, cystatin C; urine NGAL, KIM-1, 1-MG, 2-MG; preset nres txoj cai.
Q: Puas yog Shaanxi Medibridge cov chaw tsim khoom ntawm Adipotide?
A: Yog lawm, peb tsis tsuas yog muab adipotide nrog purity tsis tsawg dua 99%, tab sis Shaanxi Medibridge Biotech Co., Ltd. kuj yog tus xa khoom peptide.
Nrhiav kom ntseeg tau GLP 1 / Dual (GLP 1 / GIP) thiabPeptide adipotide hmoovchaw tsim khoom? Peb muab GMP tus qauv tswj hwm, kev tshawb fawb siv cov ntaub ntawv uas muaj COAs pob tshab, nruj ntau kom sib xws, thiab kev txhawb nqa kev ua haujlwm. Rau cov lus hais, lub sijhawm ua, lossis kev cai tshwj xeeb, hu rau hi@medibridgeapi.com lossis WhatsApp +44 07548632075.
Cim npe nrov: Tuam Tshoj peptide adipotide manufacturers, lwm tus neeg, Hoobkas



